Pure Global
NCT06414928

Prognostic Model Heart Failure

In-hospital & 30-day Prognostication of Acute Heart Failure Patients by Comparing 4 Validated Scores in Patients Presenting to the Emergency Department of Cardiac Tertiary Care Hospital, Karachi- Pakistan
National Institute of Cardiovascular Diseases, Pakistan·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Heart Failure Acute
Drug/Device/Intervention
Acute Heart Failure
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
National Institute of Cardiovascular Diseases, Pakistan
Location
Karachi, Pakistan
Timeline & enrollment
Phase
N/A
Start date
Feb 14, 2024
End date
Jun 14, 2026
Enrollment
1000 participants
Primary outcome

In-Hospital Prognosis,30-day Prognosis

Summary

This study aims to determine the prognosis of heart failure in our population by using
 multiple validated risk scores and to evaluate the strengths of these scores in assessing
 prognosis with better discrimination.

ICD-10 classifications
Heart failureHeart failure, unspecifiedCongestive heart failureInjury of heartInjury of heart, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06414928
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06414928 through Pure Global AI's free database. This phase not specified trial is sponsored by National Institute of Cardiovascular Diseases, Pakistan and is currently Recruiting. The study focuses on Heart Failure Acute. Target enrollment is 1000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.